In India, the Tier-2 and Tier-3 cities have a large cardiac and diabetic patient base, which was still unaware about pharma ...

Using half-baked knowledge in the pharmaceutical world is like trying to launch a rocket without the fuel- It’s bound to fail ...

US President Donald Trump has announced a new wave of tariffs, including a 100% levy on branded or patented drug imports from ...

What are the visible trends in pharmacy trade that you sight being in the business for a while?

Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. ESSA Pharma ( (EPIX)) just unveiled an ...

President Donald Trump signed a memo on Sept. 9 to increase enforcement actions against companies that use direct-to-consumer pharmaceutical advertisements and do not adequately disclose side effects ...

Antev is developing Teverelix, a next generation GnRH Antagonist, as a first in class market product for Acute Urinary Retention (AURr) and high CV risk Prostate Cancer collecting representing ~US$6 ...

The Trump administration is targeting "misleading drug advertisements" by initiating rule making to close a 1997 loophole that enables drug advertisers to conceal safety risks in broadcast and digital ...

The administration aims to increase transparency and accuracy in DTC pharmaceutical advertising by enforcing stricter FDA regulations. Closing the "adequate provision" loophole is a priority to ...

India’s CDMO sector surges with leading global outsourcing growth. Indian Contract Development and Manufacturing Organizations (CDMOs) are rising to the helm of the pharmaceutical sector, capitalizing ...

Aurobindo Pharma share price declined in the opening trade on September 8 following the company received eight observations from the United States Food and Drug Administration (USFDA). At 09:25am, ...

An active pharmaceutical ingredients manufacturing facility of Aurobindo Pharma subsidiary Apitoria Pharma near Hyderabad has been issued five observations by the U.S. Food and Drug Administration.